Aspirus Wausau Hospital
- Type
- Teaching hospital
- Where
- Wausau, WI
- Medicare CCN
- 520030
- Received
- $336,371 in 57 records, 2020 ($121,288 general, $215,083 research)
- Source
- CMS Open Payments search ↗
On this site
- Nonprofit contractor: ASPIRUS WAUSAU HOSPITAL INC Fuzzy (name and state)
- Plan sponsor: ASPIRUS WAUSAU HOSPITAL, INC. Fuzzy (name and state)
- Federal award recipient: ASPIRUS WAUSAU HOSPITAL, INC. Fuzzy (name and state)
- Nonprofit: ASPIRUS WAUSAU HOSPITAL INC Fuzzy (name and state)
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2020 | General payment | 29 | $121,288 |
| 2020 | Research payment | 28 | $215,083 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| Orthofix Medical, Inc. | 24 | $210,714 | 2020 |
| Olympus America Inc. | 1 | $84,770 | 2020 |
| Linvatec Corporation | 2 | $9,216 | 2020 |
| AstraZeneca Pharmaceuticals LP | 3 | $3,000 | 2020 |
| Genentech, Inc. | 2 | $2,523 | 2020 |
| Amgen Inc. | 2 | $2,250 | 2020 |
| Lilly USA, LLC | 2 | $2,250 | 2020 |
| CVRx, Inc. | 1 | $1,750 | 2020 |
| Merck Sharp & Dohme LLC | 2 | $1,596 | 2020 |
| PFIZER INC. | 1 | $1,500 | 2020 |
| Abbott Laboratories | 1 | $1,500 | 2020 |
| Amarin Pharma, Inc. | 1 | $1,500 | 2020 |
| E.R. Squibb & Sons, L.L.C. | 1 | $1,500 | 2020 |
| SANOFI-AVENTIS U.S. LLC | 1 | $1,500 | 2020 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $1,500 | 2020 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $1,500 | 2020 |
| Medline Industries LP | 2 | $1,101 | 2020 |
| Janssen Biotech, Inc. | 1 | $750 | 2020 |
| Incyte Corporation | 1 | $750 | 2020 |
| Gilead Sciences, Inc. | 1 | $750 | 2020 |
| Exelixis Inc. | 1 | $750 | 2020 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $750 | 2020 |
| AMAG Pharmaceuticals, Inc. | 1 | $750 | 2020 |
| JAZZ PHARMACEUTICALS INC. | 1 | $750 | 2020 |
| EMD Serono, Inc. | 1 | $750 | 2020 |
| GE HEALTHCARE | 1 | $699 | 2020 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Research payment | 28 | $215,083 |
| Gift | 1 | $84,770 |
| Space rental or facility fees (teaching hospital only) | 21 | $23,250 |
| Grant | 4 | $11,466 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 2 | $1,101 |
| Education | 1 | $699 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2020-12-31 | Linvatec Corporation | $154 | Grant | In-kind items and services | CONMED 3DHD VIDEO SYSTEMS Device, ORTHOPEDIC SURGERY | 2020 | |
| 2020-12-10 | Orthofix Medical, Inc. | $2,911 | Research payment | Cash or cash equivalent | Physio-Stim Osteogenesis Stimulator Device, Stimulator, Bone Growth, Non-Invasive | CP-1702 SSPM | 2020 |
| 2020-12-04 | GE HEALTHCARE | $699 | Education | Cash or cash equivalent | 2020 | ||
| 2020-12-03 | Orthofix Medical, Inc. | $2,800 | Research payment | Cash or cash equivalent | Cervical-Stim Osteogenesis Stimulator Device, Stimulator, Bone Growth, Non-Invasive | CP-1702 SSPM | 2020 |
| 2020-12-03 | Orthofix Medical, Inc. | $2,400 | Research payment | Cash or cash equivalent | Spinal-Stim Osteogenesis Stimulator Device, Stimulator, Bone Growth, Non-Invasive | CP-1703 CSPM | 2020 |
| 2020-11-24 | Linvatec Corporation | $9,061 | Grant | In-kind items and services | 2DHD CAMERA HEADS Device, ORTHOPEDIC SURGERY | 2020 | |
| 2020-11-12 | Medline Industries LP | $607 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Reprocessed Instruments Medical Supply, Reprocessing | 2020 | |
| 2020-11-04 | Olympus America Inc. | $84,770 | Gift | In-kind items and services | Ultrasonic Generators Device, Urology/Gynecology | 2020 | |
| 2020-10-29 | Orthofix Medical, Inc. | $1,846 | Research payment | Cash or cash equivalent | Cervical-Stim Osteogenesis Stimulator Device, Stimulator, Bone Growth, Non-Invasive | CP-1702 SSPM | 2020 |
| 2020-10-26 | Genentech, Inc. | $841 | Research payment | Cash or cash equivalent | Avastin Biological, BioOncology | A PHASE III MULTICENTER RANDOMIZED PLACEBO CONTROLLED STUDY OF ATEZOLIZUMAB VERSUS PLACEBO IN COM | 2020 |
| 2020-09-29 | Orthofix Medical, Inc. | $5,112 | Research payment | Cash or cash equivalent | Cervical-Stim Osteogenesis Stimulator Device, Stimulator, Bone Growth, Non-Invasive | CP-1702 SSPM | 2020 |
| 2020-09-29 | Orthofix Medical, Inc. | $2,911 | Research payment | Cash or cash equivalent | Spinal-Stim Osteogenesis Stimulator Device, Stimulator, Bone Growth, Non-Invasive | CP-1703 CSPM | 2020 |
| 2020-08-27 | Genentech, Inc. | $1,682 | Research payment | Cash or cash equivalent | Avastin Biological, BioOncology | A PHASE III MULTICENTER RANDOMIZED PLACEBO CONTROLLED STUDY OF ATEZOLIZUMAB VERSUS PLACEBO IN COM | 2020 |
| 2020-08-27 | Orthofix Medical, Inc. | $1,420 | Research payment | Cash or cash equivalent | Physio-Stim Osteogenesis Stimulator Device, Stimulator, Bone Growth, Non-Invasive | CP-1702 SSPM | 2020 |
| 2020-08-27 | Orthofix Medical, Inc. | $710 | Research payment | Cash or cash equivalent | Physio-Stim Osteogenesis Stimulator Device, Stimulator, Bone Growth, Non-Invasive | CP-1703 CSPM | 2020 |
| 2020-08-06 | Orthofix Medical, Inc. | $2,911 | Research payment | Cash or cash equivalent | Cervical-Stim Osteogenesis Stimulator Device, Stimulator, Bone Growth, Non-Invasive | CP-1702 SSPM | 2020 |
| 2020-07-17 | CVRx, Inc. | $1,750 | Research payment | Cash or cash equivalent | Barostim Neo System Device, Heart Failure and Hypertension | 2020 | |
| 2020-07-15 | Orthofix Medical, Inc. | $5,538 | Research payment | Cash or cash equivalent | Physio-Stim Osteogenesis Stimulator Device, Stimulator, Bone Growth, Non-Invasive | CP-1703 CSPM | 2020 |
| 2020-07-15 | Orthofix Medical, Inc. | $5,200 | Research payment | Cash or cash equivalent | Cervical-Stim Osteogenesis Stimulator Device, Stimulator, Bone Growth, Non-Invasive | CP-1702 SSPM | 2020 |
| 2020-07-15 | Orthofix Medical, Inc. | $3,266 | Research payment | Cash or cash equivalent | Spinal-Stim Osteogenesis Stimulator Device, Stimulator, Bone Growth, Non-Invasive | CP-1702 SSPM | 2020 |
| 2020-07-15 | Orthofix Medical, Inc. | $1,500 | Research payment | Cash or cash equivalent | Physio-Stim Osteogenesis Stimulator Device, Stimulator, Bone Growth, Non-Invasive | CP-1703 CSPM | 2020 |
| 2020-07-15 | Orthofix Medical, Inc. | $1,500 | Research payment | Cash or cash equivalent | Physio-Stim Osteogenesis Stimulator Device, Stimulator, Bone Growth, Non-Invasive | CP-1703 CSPM | 2020 |
| 2020-06-23 | Medline Industries LP | $494 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Reprocessed Instruments Medical Supply, Reprocessing | 2020 | |
| 2020-06-18 | Merck Sharp & Dohme LLC | $96 | Research payment | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of MK-3475 as Adjuvant Therapy for Triple Receptor-Neg | 2020 |
| 2020-06-11 | Orthofix Medical, Inc. | $3,200 | Research payment | Cash or cash equivalent | Cervical-Stim Osteogenesis Stimulator Device, Stimulator, Bone Growth, Non-Invasive | CP-1703 CSPM | 2020 |
| 2020-06-11 | Orthofix Medical, Inc. | $1,846 | Research payment | Cash or cash equivalent | Spinal-Stim Osteogenesis Stimulator Device, Stimulator, Bone Growth, Non-Invasive | CP-1703 CSPM | 2020 |
| 2020-05-14 | Orthofix Medical, Inc. | $13,774 | Research payment | Cash or cash equivalent | Cervical-Stim Osteogenesis Stimulator Device, Stimulator, Bone Growth, Non-Invasive | CP-1702 SSPM | 2020 |
| 2020-04-15 | Orthofix Medical, Inc. | $6,958 | Research payment | Cash or cash equivalent | Physio-Stim Osteogenesis Stimulator Device, Stimulator, Bone Growth, Non-Invasive | CP-1702 SSPM | 2020 |
| 2020-04-15 | Orthofix Medical, Inc. | $2,201 | Research payment | Cash or cash equivalent | Spinal-Stim Osteogenesis Stimulator Device, Stimulator, Bone Growth, Non-Invasive | CP-1703 CSPM | 2020 |
| 2020-04-05 | EMD Serono, Inc. | $750 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2020 | ||
| 2020-03-12 | Orthofix Medical, Inc. | $26,909 | Research payment | Cash or cash equivalent | Physio-Stim Osteogenesis Stimulator Device, Stimulator, Bone Growth, Non-Invasive | CP-1702 SSPM | 2020 |
| 2020-03-12 | Orthofix Medical, Inc. | $1,420 | Research payment | Cash or cash equivalent | Cervical-Stim Osteogenesis Stimulator Device, Stimulator, Bone Growth, Non-Invasive | CP-1703 CSPM | 2020 |
| 2020-02-28 | JAZZ PHARMACEUTICALS INC. | $750 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | VYXEOS Drug, HEMATOLOGY/ONCOLOGY | 2020 | |
| 2020-02-26 | Bayer Healthcare Pharmaceuticals Inc. | $750 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Xofigo Drug, Oncology | 2020 | |
| 2020-02-20 | Orthofix Medical, Inc. | $85,413 | Research payment | Cash or cash equivalent | Physio-Stim Osteogenesis Stimulator Device, Stimulator, Bone Growth, Non-Invasive | CP-1702 SSPM | 2020 |
| 2020-02-20 | Orthofix Medical, Inc. | $10,863 | Research payment | Cash or cash equivalent | Physio-Stim Osteogenesis Stimulator Device, Stimulator, Bone Growth, Non-Invasive | CP-1703 CSPM | 2020 |
| 2020-02-12 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $1,500 | Grant | Cash or cash equivalent | LifeVest Device, Electromedical and Electrotherapeutic Apparatus | 2020 | |
| 2020-02-07 | SANOFI-AVENTIS U.S. LLC | $1,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | SOLIQUA 100/33 Biological, Endocrinology | 2020 | |
| 2020-02-07 | Amarin Pharma, Inc. | $1,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Vascepa Drug, Cardiovascular | 2020 | |
| 2020-02-07 | Merck Sharp & Dohme LLC | $1,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | ROTATEQ Biological, VACCINE | 2020 | |
| 2020-01-30 | Abbott Laboratories | $1,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Fortify Assura Ellipse ICD Device, Cardiac Arrhythmias and Heart Failure | 2020 | |
| 2020-01-29 | Lilly USA, LLC | $1,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2020 | ||
| 2020-01-29 | AMAG Pharmaceuticals, Inc. | $750 | Grant | Cash or cash equivalent | FERAHEME Drug, PARENTERAL IRON REPLACEMENT | 2020 | |
| 2020-01-29 | Janssen Biotech, Inc. | $750 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | DARZALEX Biological, Oncology | 2020 | |
| 2020-01-29 | Gilead Sciences, Inc. | $750 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2020 | ||
| 2020-01-27 | PFIZER INC. | $1,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | ELIQUIS Drug, CARDIOVASCULAR;METABOLIC DISEASE | 2020 | |
| 2020-01-27 | Boehringer Ingelheim Pharmaceuticals, Inc. | $1,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2020 | ||
| 2020-01-27 | Lilly USA, LLC | $750 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2020 | ||
| 2020-01-24 | Amgen Inc. | $750 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Blincyto Biological, Oncology | 2020 | |
| 2020-01-23 | Incyte Corporation | $750 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | JAKAFI Drug, Hematology/Oncology | 2020 | |
| 2020-01-22 | Exelixis Inc. | $750 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Cabometyx Drug, Oncology | 2020 | |
| 2020-01-16 | AstraZeneca Pharmaceuticals LP | $750 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | LYNPARZA Drug, Oncology | 2020 | |
| 2020-01-16 | AstraZeneca Pharmaceuticals LP | $750 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | IMFINZI Drug, Oncology | 2020 | |
| 2020-01-15 | Orthofix Medical, Inc. | $18,105 | Research payment | Cash or cash equivalent | Physio-Stim Osteogenesis Stimulator Device, Stimulator, Bone Growth, Non-Invasive | CP-1702 SSPM | 2020 |
| 2020-01-15 | Amgen Inc. | $1,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Corlanor Drug, Cardiology | 2020 | |
| 2020-01-09 | E.R. Squibb & Sons, L.L.C. | $1,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | ELIQUIS Drug, Cardiovascular | 2020 | |
| 2020-01-08 | AstraZeneca Pharmaceuticals LP | $1,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | BRILINTA Drug, Cardiovascular and Metabolism | 2020 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Wausau, WI, county Marathon County, WI, state Wisconsin; placed by its city name.
| Measure | Place (city or town) Wausau, WI | County Marathon County, WI | State Wisconsin |
|---|---|---|---|
| Population B01003 | 39,996 | 138,403 | 5,914,872 |
| Population, 2020 census P1 | 39,994 | 138,013 | 5,893,718 |
| Median age B01002 | 38.2 | 41.3 | 40.2 |
| Under 18 B01001 | 22.0% | 22.5% | 21.4% |
| 65 and over B01001 | 19.4% | 19.2% | 18.5% |
| Households B11001 | 17,625 | 57,866 | 2,479,480 |
| Foreign born B05002 | 7.6% | 4.3% | 5.2% |
| Median household income B19013 | $64,389 | $77,884 | $77,485 |
| Median family income B19113 | $85,128 | $98,320 | $100,141 |
| Per capita income B19301 | $35,957 | $41,413 | $43,373 |
| Poverty rate B17001 | 14.6% | 8.7% | 10.6% |
| Unemployment rate B23025 | 4.9% | 2.9% | 3.2% |
| Civilian labor force B23025 | 20,955 | 74,273 | 3,132,770 |
| Mean commute (minutes) B08013 | 15.4 | 19.1 | 22.2 |
| Bachelor's degree or higher B15003 | 30.9% | 28.1% | 33.4% |
| Housing units B25001 | 18,718 | 60,910 | 2,778,572 |
| Owner-occupied B25003 | 57.6% | 73.3% | 67.8% |
| Renters B25003 | 42.4% | 26.7% | 32.2% |
| Median home value B25077 | $167,900 | $219,600 | $266,500 |
| Median gross rent B25064 | $1,010 | $999 | $1,087 |
| White, not Hispanic B03002 | 77.6% | 86.2% | 78.6% |
| Black B03002 | 0.4% | 0.6% | 5.9% |
| Hispanic or Latino B03002 | 5.4% | 3.5% | 8.0% |
| Asian B03002 | 10.4% | 5.7% | 2.9% |
| American Indian and Alaska Native B03002 | 0.1% | 0.1% | 0.5% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Wausau, WI.
Comments